Spencer David M.
Insider CIK 1627362 · BLCM Chief Technology Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-02-01 | 2019-02-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2019-01-03 | 2019-01-04 | 1,562 | — | $0 | 3,125 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | F Tax w/h | 2019-01-03 | 2019-01-04 | 589 | $3.20 | $1.9K | 92,470 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2019-01-03 | 2019-01-04 | 1,562 | — | $0 | 93,059 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2019-01-02 | 2019-01-04 | 2,500 | — | $0 | 7,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2019-01-02 | 2019-01-04 | 2,500 | — | $0 | 92,439 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | F Tax w/h | 2019-01-02 | 2019-01-04 | 942 | $3.33 | $3.1K | 91,497 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2018-09-04 | 2018-09-05 | 10,000 | $7.04 | $70.4K | 89,939 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2018-07-18 | 2018-07-20 | 40,000 | $7.63 | $305.2K | 99,939 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-07-02 | 2018-07-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2018-01-03 | 2018-01-05 | 1,563 | — | $0 | 4,687 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | F Tax w/h | 2018-01-03 | 2018-01-05 | 589 | $9.79 | $5.8K | 139,939 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2018-01-03 | 2018-01-05 | 1,563 | — | $0 | 140,528 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2017-07-10 | 2017-07-12 | 10,000 | $11.54 | $115.4K | 138,965 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-07-03 | 2017-07-06 | 26,250 | — | $0 | 26,250 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 6,250 | — | $0 | 6,250 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 11,250 | — | $0 | 11,250 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-12-05 | 2016-12-05 | 5,000 | $20.00 | $100.0K | 146,082 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-12-01 | 2016-12-05 | 2,967 | $17.17 | $50.9K | 153,115 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-12-01 | 2016-12-05 | 2,033 | $18.04 | $36.7K | 151,082 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-23 | 2016-09-23 | 6,200 | $20.19 | $125.2K | 156,082 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-22 | 2016-09-23 | 10,000 | $19.68 | $196.8K | 162,282 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-21 | 2016-09-23 | 300 | $20.04 | $6.0K | 172,282 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-20 | 2016-09-20 | 100 | $20.00 | $2.0K | 172,582 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-19 | 2016-09-20 | 700 | $20.02 | $14.0K | 172,682 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-16 | 2016-09-20 | 1,700 | $20.01 | $34.0K | 173,382 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-08-15 | 2016-08-17 | 1,000 | $20.00 | $20.0K | 175,082 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-07-27 | 2016-07-29 | 10,000 | $15.00 | $150.0K | 176,082 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-01-04 | 2016-01-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2015-12-14 | 2015-12-16 | 5,000 | — | $0 | 117,058 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2015-12-14 | 2015-12-16 | 5,000 | $2.55 | $12.8K | 184,559 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-12-01 | 2015-12-03 | 5,000 | $22.95 | $114.8K | 178,600 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2015-09-21 | 2015-09-23 | 5,000 | — | $0 | 122,058 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2015-09-21 | 2015-09-23 | 5,000 | $2.55 | $12.8K | 183,600 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-09-11 | 2015-09-15 | 5,000 | $19.00 | $95.0K | 178,600 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2015-07-02 | 2015-07-07 | 20,000 | — | $0 | 127,058 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2015-07-02 | 2015-07-07 | 20,000 | $2.55 | $51.0K | 183,600 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-06-16 | 2015-06-18 | 2,800 | $23.79 | $66.6K | 162,754 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-06-16 | 2015-06-18 | 17,200 | $22.82 | $392.5K | 165,554 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-06-16 | 2015-06-19 | 17,200 | $22.82 | $392.5K | 166,400 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-06-16 | 2015-06-19 | 2,800 | $23.79 | $66.6K | 163,600 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2015-02-24 | 2015-02-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 46,284 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 27,225 | — | $0 | 182,754 | SEC↗ |